The Effect of Chinese Medicine on Lipid and Glucose Metabolism in Acute Myocardial Infarction Through PPARγ Pathway

about

The Effect of Chinese Medicine on Lipid and Glucose Metabolism in Acute Myocardial Infarction Through PPARγ Pathway

Item

http://www.wikidata.org/entity/Q58566957

description

article

@en

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

The Effect of Chinese Medicine ...... farction Through PPARγ Pathway

@en

The Effect of Chinese Medicine ...... farction Through PPARγ Pathway

@nl

type

Item

label

The Effect of Chinese Medicine ...... farction Through PPARγ Pathway

@en

The Effect of Chinese Medicine ...... farction Through PPARγ Pathway

@nl

prefLabel

The Effect of Chinese Medicine ...... farction Through PPARγ Pathway

@en

The Effect of Chinese Medicine ...... farction Through PPARγ Pathway

@nl

P1476

The Effect of Chinese Medicine ...... farction Through PPARγ Pathway

@en

P2093

Chun Li

http://www.w3.org/2001/XMLSchema#string

Dongqing Guo

http://www.w3.org/2001/XMLSchema#string

Mingyan Shao

http://www.w3.org/2001/XMLSchema#string

Qian Zhang

http://www.w3.org/2001/XMLSchema#string

Qiyan Wang

http://www.w3.org/2001/XMLSchema#string

Xiaomin Yang

http://www.w3.org/2001/XMLSchema#string

Xuefeng Zhang

http://www.w3.org/2001/XMLSchema#string

Yong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Qishenyiqi protects ligation-induced left ventricular remodeling by attenuating inflammation and fibrosis via STAT3 and NF-κB signaling pathway

Hypoxia-driven glycolytic and fructolytic metabolic programs: Pivotal to hypertrophic heart disease.

CD36 is essential for endurance improvement, changes in whole-body metabolism, and efficient PPAR-related transcriptional responses in the muscle with exercise training.

Imaging of Myocardial Ischemia-Reperfusion Injury Using Sodium [18F]Fluoride Positron Emission Tomography/Computed Tomography in Rats and Humans.

Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling.

The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a literature review.

DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4.

Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway.

Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease.

The effect of Chinese herbs and its effective components on coronary heart disease through PPARs-PGC1α pathway.

P304

1209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.01209

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30405421

http://www.w3.org/2001/XMLSchema#string

P921

Aat atak

Farmakologi

glucose

P932

6207917

http://www.w3.org/2001/XMLSchema#string